• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名绝经后患者的纯卵巢无性细胞瘤:病例报告及治疗回顾

Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management.

作者信息

Vaz Jennifer, Mulliken Alexandra, Omar Nivin, Suhner Jessa, Brzezinska Bogna, Cotter Thomas, Nikhil Patel, Higgins Robert V, Rungruang Bunja

机构信息

Division of Gynecologic Oncology, Medical College of Georgia at Augusta University, Augusta, GA, United States.

Pathology Department, Medical College of Georgia at Augusta University, Augusta, GA, United States.

出版信息

Gynecol Oncol Rep. 2022 Sep 17;43:101068. doi: 10.1016/j.gore.2022.101068. eCollection 2022 Oct.

DOI:10.1016/j.gore.2022.101068
PMID:36212092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9535265/
Abstract

BACKGROUND

A pure ovarian dysgerminoma in a postmenopausal female is a rare phenomenon.

CASE

A 65-year-old female presented with a large pelvic mass. Following surgical debulking, the patient was diagnosed with FIGO Stage IIB ovarian dysgerminoma. She was treated with three cycles of etoposide and cisplatin and has been disease-free for 12 months.

CONCLUSION

Dysgerminomas in postmenopausal females are uncommon. Gynecologic oncologists should be familiar with the pathological diagnosis and treatment recommendations to achieve optimal outcomes.

摘要

背景

绝经后女性单纯性卵巢无性细胞瘤是一种罕见现象。

病例

一名65岁女性因盆腔巨大肿块就诊。手术减瘤后,患者被诊断为国际妇产科联盟(FIGO)IIB期卵巢无性细胞瘤。她接受了三个周期的依托泊苷和顺铂治疗,目前已无病生存12个月。

结论

绝经后女性的无性细胞瘤并不常见。妇科肿瘤学家应熟悉其病理诊断和治疗建议,以实现最佳治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c43/9535265/e7424a69d2c1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c43/9535265/e7424a69d2c1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c43/9535265/e7424a69d2c1/gr1.jpg

相似文献

1
Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management.一名绝经后患者的纯卵巢无性细胞瘤:病例报告及治疗回顾
Gynecol Oncol Rep. 2022 Sep 17;43:101068. doi: 10.1016/j.gore.2022.101068. eCollection 2022 Oct.
2
[Management of intra-abdominal dysgerminoma During pregnancy - A Case Report and Literature Review].[妊娠期腹腔内无性细胞瘤的管理——病例报告及文献综述]
Z Geburtshilfe Neonatol. 2020 Oct;224(5):306-314. doi: 10.1055/a-1112-0506. Epub 2020 Apr 2.
3
Metastasis of ovarian dysgerminoma in a postmenopausal patient: a rare case report.绝经后患者卵巢无性细胞瘤转移:一例罕见病例报告
Ann Med Surg (Lond). 2024 May 6;86(8):4788-4792. doi: 10.1097/MS9.0000000000002135. eCollection 2024 Aug.
4
Trisomy 21 associated with ovarian dysgerminoma.
Gynecol Oncol. 1999 Sep;74(3):512-4. doi: 10.1006/gyno.1999.5453.
5
Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.性发育障碍(DSD)患者的卵睾细胞瘤和生殖细胞瘤以及卵巢生殖细胞瘤中 c-KIT 突变的流行情况。
PLoS One. 2012;7(8):e43952. doi: 10.1371/journal.pone.0043952. Epub 2012 Aug 28.
6
Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.卵巢无性细胞瘤的晚期复发及对标准辅助化疗的成功反应:一例病例报告并文献复习
Gynecol Oncol. 2001 May;81(2):314-7. doi: 10.1006/gyno.2001.6135.
7
Cranial and intra-axial metastasis originating from a primary ovarian Dysgerminoma.源于原发性卵巢无性细胞瘤的颅内和轴内转移
Gynecol Oncol Rep. 2019 Jun 22;29:55-57. doi: 10.1016/j.gore.2019.06.006. eCollection 2019 Aug.
8
[A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].[1例经VeIP疗法成功治疗的顺铂耐药(BEP方案耐药)卵巢无性细胞瘤]
Gan To Kagaku Ryoho. 2009 Mar;36(3):513-7.
9
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?基于卡铂的化疗与基于顺铂的化疗在治疗儿童、青少年和年轻成人晚期生殖细胞瘤中的疗效是否相当?
Gynecol Oncol. 2018 Aug;150(2):253-260. doi: 10.1016/j.ygyno.2018.05.025. Epub 2018 Jun 5.
10
Ovarian dysgerminoma in pregnancy: A case report and literature review.妊娠性卵巢未成熟畸胎瘤:病例报告及文献复习。
Cancer Biol Ther. 2018 Aug 3;19(8):649-658. doi: 10.1080/15384047.2018.1450118. Epub 2018 Apr 25.

引用本文的文献

1
Metastasis of ovarian dysgerminoma in a postmenopausal patient: a rare case report.绝经后患者卵巢无性细胞瘤转移:一例罕见病例报告
Ann Med Surg (Lond). 2024 May 6;86(8):4788-4792. doi: 10.1097/MS9.0000000000002135. eCollection 2024 Aug.

本文引用的文献

1
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.四周期依托泊苷联合顺铂治疗低危晚期生殖细胞肿瘤
Oncologist. 2021 Jun;26(6):483-491. doi: 10.1002/onco.13719. Epub 2021 Mar 12.
2
Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.派姆单抗治疗晚期转移性生殖细胞肿瘤患者。
Oncologist. 2021 Jul;26(7):558-e1098. doi: 10.1002/onco.13682. Epub 2021 Feb 12.
3
Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors.单纯型卵巢生殖细胞瘤:13 例肿瘤的 CT 和 MRI 特征与病理相关性。
J Ovarian Res. 2020 Jun 17;13(1):71. doi: 10.1186/s13048-020-00674-z.
4
Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review.绝经后患者的恶性卵巢生殖细胞肿瘤:皇家马斯登医院的经验及文献综述
Anticancer Res. 2015 Dec;35(12):6713-22.
5
The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders.免疫组织化学在妇科疾病鉴别诊断中的应用
Arch Pathol Lab Med. 2015 Jan;139(1):39-54. doi: 10.5858/arpa.2014-0057-RA.
6
Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).恶性卵巢生殖细胞肿瘤的预后因素(监测、流行病学和最终结果经验 1978-2010)。
Eur J Cancer. 2014 Jul;50(11):1942-50. doi: 10.1016/j.ejca.2014.03.288. Epub 2014 May 20.
7
Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.用卡铂和依托泊苷对完全切除的无性细胞瘤进行辅助治疗:妇科肿瘤学组的一项试验
Gynecol Oncol. 2004 Dec;95(3):496-9. doi: 10.1016/j.ygyno.2004.07.044.
8
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.博来霉素、依托泊苷和顺铂三或四个周期化疗与3天或5天疗程在预后良好的生殖细胞癌中的等效性:欧洲癌症研究与治疗组织泌尿生殖系统癌症合作组和医学研究理事会的一项随机研究
J Clin Oncol. 2001 Mar 15;19(6):1629-40. doi: 10.1200/JCO.2001.19.6.1629.
9
Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.顺铂、依托泊苷和博来霉素用于卵巢生殖细胞肿瘤的辅助治疗:妇科肿瘤学组的一项试验
J Clin Oncol. 1994 Apr;12(4):701-6. doi: 10.1200/JCO.1994.12.4.701.
10
Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.顺铂、长春碱和博来霉素用于晚期及复发性卵巢生殖细胞肿瘤。妇科肿瘤学组的一项试验。
Ann Intern Med. 1989 Jul 1;111(1):22-7. doi: 10.7326/0003-4819-111-1-22.